Actively Recruiting
68Ga-NYM096 PET/CT in Various Kinds of Cancer
Led by Peking Union Medical College Hospital · Updated on 2025-09-05
120
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, single-center study aimed at evaluating the uptake characteristics of 68Ga-NYM096 PET/CT in various kinds of tumors including primary and metastatic lesions. Based on image analysis, this study will assess the uptake of various kinds of tumors using 68Ga-NYM096 PET/CT. The findings will provide critical insights into the tumor uptake on 68Ga-NYM096 PET/CT to identify the most promising indications for future application.
CONDITIONS
Official Title
68Ga-NYM096 PET/CT in Various Kinds of Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Histopathologically confirmed cancer or radiologically clear metastatic lesions of histologically proven primary tumors
- Expected survival of at least 3 months
- Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
- Provided written informed consent for trial participation
- Willing and able to comply with required study procedures as judged by the investigator
You will not qualify if you...
- Received VEGF TKI treatment less than 1 week before 68Ga-NYM096 PET/CT scan
- Medical conditions that make the patient unsuitable for study procedures
- Pregnancy or breastfeeding
- Severe claustrophobia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital, Beijing, Beijing 100730
Beijing, China, 100730
Actively Recruiting
Research Team
L
Li Huo, MD
CONTACT
W
Wenjia Zhu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here